Search results

22 items matching your search terms.
Filter the results.
Item type











New items since



Sort by relevance · date (newest first) · alphabetically
"Discovery at UNC points to possible environmental cause of autism"
Located in News
Simons Foundation Autism Research Initiative features recent findings by Ben Philpot and Mark Zylka in its news article, "Autism genes are surprisingly large, study finds."
Located in News
Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment
April 2012 - Zylka lab publication in the journal "Molecular Pain" outlines the pain relief potential of PAP injections.
Located in News
Molecular bandit keeps pain at bay
Mark Zylka and colleagues have identified an enzyme that blocks chronic pain by robbing a major pain pathway of a key ingredient. The enzyme could prevent lasting pain after surgery.
Located in News
August 2013 - Findings published in the journal Nature outline the effects that key enzymes called topoisomerases can have on the genetic machinery behind brain development.
Located in News
The work of Mark Zylka, PhD, and Ben Philpot, PhD, is featured by Autism Speaks in its list of 10 major advances in autism research in 2013.
Located in News
Zylka lab's Bonnie Taylor-Blake wins first place in Art of Science competition
Located in News
Zylka outlines how he started studying brain enzymes, the details and implications of his research, and what motivates him.
Located in News
Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth
December 2011 - Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.
Located in News
Mark Zylka receives Transformative R01 Grant
Assistant professor Mark Zylka was awarded one of 42 NIH Roadmap Transformative R01 grants for his project Harnessing Ectonucleotidases to Treat Chronic Pain.
Located in News